LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Lökk, Johan (2003)
Publisher: Co-Action Publishing
Journal: Food & Nutrition Research
Languages: English
Types: Article
Subjects:

Classified by OpenAIRE into

mesheuropmc: nutritional and metabolic diseases, polycyclic compounds
Normal and subnormal serum levels of vitamin B12 and/or folate do not exclude functional deficiency, and elderly people are specifically exposed to deficiency owing to impaired nutrition, malabsorption, accompanying diseases and current medication. Several studies report that low levels of vitamin B12 are more common in people with Alzheimer’s disease (AD) than in non-demented people. Low levels of folate are also correlated with other types of dementia. Current studies suggest that low levels of vitamin B12 as well as folate may be part of the aetiology in AD. A functional deficiency of vitamin B12/folate may be present despite serum levels within reference limits. The amino acid homocysteine (Hcy) is a sensitive but non-specific marker of deficiency of vitamin B12 and folate and appears to have the strongest association with cognitive function. The association between Hcy levels and cognitive function is also stronger than that of the levels of vitamin B12/fol ate. The clinical manifestations of vitamin B12/folate deficiency are non-specific, but when they are connected with laboratory findings adequate investigation should be performed. A generous attitude to treatment with vitamin B12/folate is advocated, combined with a compulsory evaluation of treatment effect. Clinical regress of neuropsychiatric symptoms by cobalamin and folate therapy is dependent on the duration and severity of symptoms, but on a group level, not necessarily in individual patients. Keywords: cognition; folate; homocysteine; vitamin B12
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Herbert V. Vitamin B12: plant sources, requirements, and assays. Am J Clin Nutr 1988; 48: 852 /8.
    • 2. Lee R. Nutritional factors in the production and function of erythrocytes. In: Lee R, et al, eds. Wintrobe's clinical hematology, 9th edn.. Philadelphia, PA: Lea & Febiger; 1993.
    • 3. Hultdin J. Vitamin B12. Molekyl, metabolism och marko¨ rer. In: Engstedt L, et al, eds. Kontroverser kring vitamin B12. Kunskap, kompetens, kommunikation. Klippan: Pedagogfo¨ rlaget; 1998. p. 23 /49.
    • 4. Wintrobe MM. Blood, pure and eloquent. New York: McGraw-Hill; 1980.
    • 5. Lo¨ kk J. Folat/B12-berikning av la¨karka˚ren la¨mplig t a¨mne pa˚ na¨sta la¨karsta¨mma. La¨kartidningen 2002; 10: 1105.
    • 6. Rajan S, et al. Screening for cobalamin deficiency in geriatric outpatients: prevalence and influence of synthetic cobalamin intake. J Am Geriatr Soc 2002; 50: 624 /6230.
    • 7. Haller J. The vitamin status and its adequacy in the elderly: an international review. Int J Vitam Nutr Res 1999; 69: 160 /8.
    • 8. Hvaas A-M. Diagnostik og behandling af vitamin B12 mangel. Akademisk avhandling, Det sundhedsvidenskabelige Fakultet, Aarhus Universitet, Denmark; 2001.
    • 9. Nyga˚rd O, et al. Plasma total homocysteine and cardiovascular and non-cardio-vascular mortality: the Hordaland study. Am J Clin Nutr 2001; 74: 103 /36.
    • 10. Selhub J, et al. Vitamin status and intake as primary determinants of hyperhomocysteinemia in an elderly population. JAMA 1993; 270: 2693 /8.
    • 11. Finkelstein JD. Homocysteine: a history in progress. Nutr Rev 2000; 58: 193 /204.
    • 12. Schneede J, et al. Biological and environmental determinants of plasma homocysteine. Semin Thromb Hemost 2000; 26: 263 /79.
    • 13. Kang S, et al. Intermediate hyperhomocysteinemia resulting from compound heterozygosity of MTHFR mutation. Am J Hum Genet 1991; 48: 546 /51.
    • 14. Bolander-Gouaille C. Focus on homocysteine and the vitamins involved in its metabolism. Frankrike: Springer; 2002.
    • 15. Lo¨ kk J. Folat/kobalamin hos a¨ldre / bristtillsta˚nd vanliga och sva˚rfa˚ngade. La¨kartidningen 2002; 98: 5878 /82.
    • 16. Rosenberg IH, et al. Nutritional factors in physical and cognitive functions of elderly people. Am J Clin Nutr 1992; 55: 1237S /43S.
    • 17. Wang HX. Vitamin B12, folate, and Alzheimer's disease. Drug Dev Res 2002; 56: 111 /22.
    • 18. Selhub J, et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 1995; 332: 286 /91.
    • 19. Schnyder G, et al. Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention. JAMA 2002; 288: 973 /9.
    • 20. Molloy AM. Folate bioavailability and health. Int J Vitamin Nutr Res 2002; 72: 5221 /46.
    • 21. Czeizel AE. Prevention of congenital abnormalities by periconceptional multivitamin supplementation. Br Med J 1993; 306: 1645 /9.
    • 22. Wald NJ, et al. Quantifying the effect of folic acid. Lancet 2001; 358: 2069 /73.
    • 23. Munoz-Maan E, et al. Genetic selection and folate intake during pregnancy. Lancet 1998; 352: 1120 /1.
    • 24. Penninx BWJH, et al. Vitamin B12 deficiency and depression in physically disabled older women: epidemiologic evidence from the Women's Health and Aging Study. Am J Psychiatry 2000; 157: 715 /21.
    • 25. Choi SW, Mason JB. Folate and carcinogenesis: an integrated scheme. J Nutr 2002; 132(Suppl S): 129 / 32.
    • 26. Backman DL, et al. Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham study. Neurology 1992; 42: 115 /9.
    • 27. Lo¨ kk J, Sandstro¨ m H. Mentala symtom vid B12-brist / Geriatrikerns och distriktsla¨karens perspektiv. In: Engstedt L, et al., eds. Kontroverser kring vitamin B12: Kunskap, kompetens, kommunikation. Klippan, Sverige: Pedagogfo¨ rlaget; 1998.
    • 28. Joosten E, et al. Metabolic evidence that deficiencies of vitamin B12, folate, and vitamin B6 occur commonly in elderly people. Am J Clin Nutr 1993; 58: 468 /76.
    • 29. McCaddon A, Davies G. Nutritionally independent B12 deficiency and Alzheimer disease. Arch Neurol 2000; 57: 607 /8.
    • 30. Parnetti L, et al. Role of homocysteine in age-related vascular and non-vascular diseases. Aging Clin Exp Res 1997; 9: 241 /57.
    • 31. Fontanari D, et al. Effects of S -adenosyl-L-methionine on cognition and vigilance functions in the elderly. Curr Ther Res 1994; 55: 682 /99.
    • 32. Lindenbaum J, et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med 1988; 318: 1720 /8.
    • 33. Gottfries J, et al. One-carbon metabolism and other biochemical correlates of cognitive impairment as visualized by principal component analysis. J Geriatr Psychiatry Neurol 2001; 14: 109 /14.
    • 34. Leblhuber F, et al. Hyperhomocysteinemia in dementia. J Neural Transm 2000; 107: 1469 /74.
    • 35. Franchi F, et al. Deficient folate nutritional status and cognitive performances: results from a retrospective study in male elderly inpatients in a geriatric department. Arch Gerontol Geriatr 2001; 7(Suppl): 145 /50.
    • 36. Wang HX, et al. Vitamin B12 and folate in relation to the development of Alzheimer's disease. Neurology 2001; 56: 188 /94.
    • 37. Ikeda T, et al. Vitamin B12 levels in serum and cerebrospinal fluid of people with Alzheimer's disease. Acta Psychiatr Scand 1990; 82: 327 /9.
    • 38. Riggs K, et al. Relations of vitamin B12, B6, folate and homocysteine to cognitive performance in the normative aging study. Am J Clin Nutr 1996; 63: 306 /14.
    • 39. Jensen E, et al. Plasma homocysteine in 80-year-olds. Relationships to medical, psychological, and social variables. Arch Gerontol Geriatr 1998; 26: 215 /26.
    • 40. Budge M, et al. Plasma total homocysteine and cognitive performance in a volunteer elderly population. Ann N Y Acad Sci 2000; 903: 407 /10.
    • 41. Clarke RT, et al. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer's disease. Arch Neurol 1998; 55: 1449 /155.
    • 42. McCaddon A, et al. Total serum homocysteine in senile dementia of Alzheimer type. Int J Geriatr Psychiatry 1998; 13: 235 /9.
    • 43. Lehmann M, et al. Identification of cognitive impairment in the elderly. Homocysteine is an early marker. Dement Geriatr Cogn Disord 1999; 10: 12 /20.
    • 44. Nilsson K, et al. The plasma homocysteine concentration is better than that of serum methylmalonic acid as a marker for sociopsychological performance in a psychogeriatric population. Clin Chem 2000; 46: 691 /6.
    • 45. Johnson MA, et al. Hyperhomocysteinemia and vitamin B12 deficiency in elderly using Title IIIc nutrition services. Am J Clin Nutr 2003; 77: 211 /20.
    • 46. Maxwell CJ, et al. Serum folate levels and subsequent adverse cerebrovascular outcomes in elderly persons. Dement Geriatr Cogn Disord 2002; 13: 225 /34.
    • 47. McCaddon A, et al. Homocysteine and cognitive decline in healthy elderly. Dement Geriatr Cogn Disord 2001; 12: 309 /13.
    • 48. Seshadri S, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002; 346: 476 /83.
    • 49. Prins ND, et al. Homocysteine and cognitive function in the elderly / the Rotterdam Scan Study. Neurology 2002; 59: 1375 /80.
    • 50. Duthie SJ, et al. Homocysteine, B vitamin status, and cognitive function in the elderly. Am J Clin Nutr 2002; 75: 908 /13.
    • 51. van Asselt D, et al. Cobalamin supplementation improves cognitive and cerebral function in older, cobalamin-deficient persons. J Gerontol 2001; 56A: M775 /9.
    • 52. Martin D, et al. Time dependency of cognitive recovery with cobalamin replacement: report of a pilot study. J Am Geriatr Soc 1992; 40: 168 /72.
    • 53. Nilsson K, et al. Improvement of cognitive function after cobalamin/folate supplementation in elderly persons with dementia and elevated plasma homocysteine. Int J Geriatr Psychiatry 2001; 16: 609 /14.
    • 54. Nilsson K, et al. Treatment of cobalamin deficiency in dementia, evaluated clinically and with cerebral blood flow measurements. Aging Clin Exp Res 2000; 12: 199 / 207.
    • 55. Kuzminsky M, et al. Effective treatment of cobalamin deficiency with oral cobalamin. Blood 1998; 92: 1191 /8.
    • 56. Clarke RT. An overview of homocysteine lowering trials. In: Robinson K, ed. Homocysteine and causality discussion. Dordrecht: Kluwer Academic; 2000. p. 213 /29.
    • 57. Stabler SP. Screening the older population for cobalamin (vitamin B12) deficiency. J Am Geriatr Soc 1995; 32: 1290 /7.
    • 58. Lindgren A. On the diagnosis of cobalamin malabsorption. Akademisk avhandling, Medicinska Institutionen, Go¨ teborgs Universitet; 1998.
    • 59. Bates CJ, et al. Relationship between methylmalonic acid, homocysteine, vitamin B12 intake and status and socio-economic indices, in a subset of participants in the British National Diet and Nutrition Survey of people aged 65 y and over. Eur J Clin Nutr 2003; 57: 349 /57.
    • 60. Anonymous. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Homocysteine Lowering Trialists' Collaboration. Br Med J 1998; 316: 894 /8.
    • 61. Garcia A, et al. Is low-dose oral cobalamin enough to normalize cobalamin function in older people? J Am Geriatr Soc 2002; 50: 1401 /4.
    • 62. Refsum H, et al. Homocysteine and cardiovascular disease. Annu Rev Med 1998; 49: 31 /62.
    • 63. FASS (Farmaceutiska specialiteter i Sverige). Kungsbacka: Elanders; 2002.
    • 64. Nilsson K, et al. Optimal use of markers for cobalamin and folate in a psychogeriatric population. Int J Geriatr Psychiatry 2002; 17: 919 /25.
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article

Collected from